Apollomics, Inc. (APLM) vs Eloxx Pharmaceuticals, Inc. (ELOX)

A side-by-side comparison of Apollomics, Inc. and Eloxx Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

APLM

Apollomics, Inc.

$50M

$22.70HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT

ELOX

Eloxx Pharmaceuticals, Inc.

$52M

$15.00HealthcareDelayed quote: Oct 6, 2026, 11:51 AM EDT

Total return — APLM vs ELOX

growth of $100 · dividends reinvested · last 1y

APLM +62.7% (+62.7%/yr)ELOX +40.0% (+40.0%/yr)APLM compounded faster over this window

APLM ELOX

Metrics side by side

Total return (annualized)

Metric	APLM	ELOX
Total return (1Y)	26.12%	N/A
Total return CAGR (3Y)	-57.62%	N/A

ELOX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full APLM analysis Full ELOX analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.